-

kENUP Foundation: Vaccine Skepticism in Germany Multiplies With Novel COVID Vaccines

  • 13.7 million new vaccine opponents since pandemic onset;
  • skepticism mostly exacerbated by fears of long-term damage and fast vaccine approval processes, correlates with corona virus denial;
  • 90% of skeptics feel they have no influence over politics, are predominantly AfD-leaning and about 45% attained the lowest level or left secondary school without certification;
  • while new skeptics could be convinced by facts, long-term anti-vaccinationists appear to be unyielding.

KALKARA, Malta & BERN, Switzerland & LUXEMBOURG--(BUSINESS WIRE)--The first representative study of COVID-19 vaccine skeptics, conducted by kENUP Foundation, the Swiss Academies of Arts and Sciences and the EIB Institute, identified the socioeconomic and consumer behavior profile, as well as the dominant values and positions of COVID-19 vaccines skeptics and examined potential strategies to increase willingness to get a COVID-19 vaccine in that cohort.

Overall, 19.6% of the German population make up the COVID-19 vaccine skeptic group, those unlikely or very unlikely to take the jab once offered to them. Almost 84.2% of that group were not opposed to vaccines before the corona crisis. This means that 13.7 million new skeptics are contributing to the high COVID-19 anti-vaccine sentiment.

COVID-19 vaccine skepticism is mainly driven by the fear of long-term damage (66.0%), the fast approval process (54.7%) and fear of adverse health effects (53.0%). It correlates with corona virus denial: 21.7% of vaccine skeptics and 36.8% of long-term anti-vaccinationists disagree that COVID-19 causes serious health problems. Denial of the virus infecting many people worldwide is 21.8% and 40%, respectively for new skeptics and long-term anti-vaccinationists.

While 69.3% of all vaccine skeptics could be convinced to take the COVID-19 vaccine through factual assurances, 69.4% of long-term anti-vaccinationists state that nothing would convince them. On the assurances needed for attitudinal change within the overall cohort, exclusion of long-term damage (52.0%), proven effectiveness (40.8%) and the evidence that genes are not changed (32.0%) top the list. Also, neither celebrity endorsement nor prospects of long-distance travel are convincing skeptics to be vaccinated. Vaccine skeptics seem to have more trust in vaccines originating from Germany, the United States, and the United Kingdom. Vaccines from Russia, China and especially India have a low chance of approval by skeptics.

A prevailing lack of life meaning and political participation defines the cohort of vaccine skeptics: 89.2% feel that they have no influence over politics. Of the long-term anti-vaccinationists, 35.2% express existential fears and financial worries, with life lacking any perspective for 35.6% of them. In terms of political affiliation, the anti-vaccination group is predominantly AfD-leaning (43.0%, far-right), with support of FDP (liberal) and Die Linke (left) also over-represented, while affinity to SPD (centre-left), CDU/CSU (centre-right) and Die Grünen (green) remains significantly underrepresented. Anti-vaccination sentiments are much higher in people of non-Christian religions.

The full report and more information can be found at https://www.kenup.eu/press and https://www.covidx.eu

Contacts

Press contact
kENUP: Tobias Mac-Lean, maclean@kenup.eu, https://www.kenup.eu

kENUP Foundation

Details
Headquarters: Kalkara, Republic of Malta
CEO: Holm Keller
Employees: 15
Organization: NON


Contacts

Press contact
kENUP: Tobias Mac-Lean, maclean@kenup.eu, https://www.kenup.eu

More News From kENUP Foundation

Barbados’ Prime Minister Mia Amor Mottley Announces Transatlantic Bridge Between the Caribbean, Latin America and Africa to Develop and Manufacture Pharmaceuticals for Global Public Health

SHARM EL-SHEIKH, Egypt--(BUSINESS WIRE)--Today, Prime Minister of Barbados Mia Amor Mottley, President of the Co-operative Republic of Guyana H.E. Mohamed Irfaan Ali, and President of the Republic of Rwanda. H.E. Paul Kagame met in Sharm El-Sheikh on the sidelines of COP 27 to discuss the furthering of pharmaceutical equity for global public health with President of the European Commission Ursula von der Leyen, and Director-General of the World Health Organization (WHO) Dr Tedros Adhanom Ghebre...

Announcement at kENUP Roundtable: BioNTech Plans mRNA Facility in Africa in Mid-2022

KIGALI, Rwanda--(BUSINESS WIRE)--BioNTech SE today announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022. This is the next step in BioNTech’s efforts to implement sustainable end-to-end vaccine supply solutions on the African continent. The decision is the result of a meeting between Rwanda’s Minister of Health, Dr Daniel M. Ngamije, Senegal’s Minister of Foreign Affairs Aïssata Tal...

CAPRISA and Evotec Launch New Project to Fast-Track New Technology for HIV Prevention

KIGALI, Rwanda--(BUSINESS WIRE)--Today, at a side meeting during the AU-EU Ministerial Summit in Kigali, Rwanda, Prof Salim Abdool Karim, Director of CAPRISA, announced a collaboration with a leading life science company Evotec for the designing and development of CAP256, a broadly neutralizing antibody against HIV. The project is a major expansion of the development of an antibody originally developed jointly by CAPRISA and the Vaccine Research Center (VRC) of the National Institute of Allergy...
Back to Newsroom